Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Bristol Myers defends pipeline, reinforces later stage BD interest

Bristol Myers Squibb is re-emphasizing its plan to stave off one of the industry’s most daunting patent cliffs. Speaking to analysts on its earnings call on Thursday, executives at the New Jersey pharma company touted ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 29 October →